ISO 8637-3 2024 Versus ISO 8637-3 2018
Extracorporeal systems for blood purification Part 3: Plasmafilters
General information
Valid from 05.07.2026
Directives or regulations
none
Handling area Give feedback
This ISO 8637-3 2024 vs 2018 comparison helps manufacturers and regulatory teams quickly identify what has changed in the requirements and test methods for plasmafilters. Our gap analysis breaks down clause-by-clause revisions, so your team can update device documentation and validation processes without re-reading the entire standard.
This standard specifies requirements and test methods for plasmafilters — devices intended to separate plasma from blood during therapeutic plasmapheresis therapy. It covers sterile, single-use plasmafilters intended for use on humans, referred to collectively as "the device."
The standard does not apply to:
Extracorporeal blood circuits
Haemodialysers, haemodiafilters, haemofilters and haemoconcentrators
Haemoperfusion devices
Vascular access devices
Blood pumps
Systems or equipment intended to perform plasma separation
Whether you're updating a Design History File, preparing regulatory submissions, or responding to a notified body query, this ISO 8637-3 2024 vs 2018 report gives you a clear, audit-ready summary of exactly what's changed between the two revisions.
Related products
Healthcare, ISO
Healthcare, ISO
ISO 10993-6:2026 vs ISO 10993-6:2016
Biological evaluation of medical devices Part 6: Tests for local effects after implantation
Healthcare, ISO
ISO 7199-2024 Vs ISO 7199-2017
Cardiovascular implants and artificial organs — Blood-gas exchangers (oxygenators)
ISO, Software
ISO 29100:2024 VERSUS ISO 29100:2020
Information technology — Security techniques — Privacy framework.
Healthcare, ISO
ISO 8637-3 2024 Versus ISO 8637-3 2018
Price range: $1.00 through $95.00
Extracorporeal systems for blood purification
Part 3: Plasmafilters